Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional Respiratory Imaging to assess short-term effect of Orkambi in cystic fibrosis (F508del homozygous)
2018-001573-24Phase 4Completed
- Sponsor
- Antwerp University Hospital
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lumacaftor + ivacaftor in cystic fibrosis (CF), sponsored by Antwerp University Hospital. Primary endpoint: FRI parameters (primary). Started May 2018; status: completed.
02
Drugs
lumacaftor + ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2018-001573-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001573-24.